ERCC1 and cancer: For instance, a correlation was observed between decreased expression of ERCC1 and unfavorable overall survival (OS) in ten types of cancers, namely BRCA, CESC, CHOL, ESCA, GBM, HNSC, LUSC, PAAD, PCPG, and PRAD.